Clinical trials: Sexuality and Reproductive Issues
Prostatic Diseases
Benign Prostatic Hyperplasia in Taiwan
Primary Objective: To assess the sexual function of Benign Prostatic Hyperplasia patients Secondary Objective: To evaluate the association between Lower Urinary Tract Symptoms severity and sexual disorders To compare the sexual…
- Trial name
- NCT00941343
- Testing
- Alfuzosin (XATRAL® - SL770499)
- Where
- Taiwan
- Volunteers
- 362 people
- Sponsor
- Sanofi
Adolescent Pregnancy, Sexually Transmitted Diseases
A Parent Child Program to Prevent Adolescent Pregnancy
While the U.S. teen birth rate is currently at its lowest level, it remains high in relation to other industrialized countries and continues to be a public health concern due to health risks for teen mothers and their babies, and…
- Conditions
- Adolescent Pregnancy, Sexually Transmitted Diseases, Parental, Communication
- Trial name
- PPP_2 (NCT02333019)
- Testing
- Let's Talk About Sex, Websites; preventing teen pregnancy
- Where
- United States
- Volunteers
- 395 people, healthy volunteers welcome
- Sponsor
- Oregon Center for Applied Science, Inc.
Prostatic Hyperplasia
SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
Primary Objective: To assess the sexual function improvement from baseline to the end of treatment (Week 24 or premature withdrawal (PW)) with XATRAL 10mg OD.
- Trial name
- NCT00486785
- Testing
- Alfuzosin
- Where
- 4 sites in Colombia, Ecuador and 2 more
- Volunteers
- 431 people
- Sponsor
- Sanofi
Prostatic Hyperplasia
Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
Primary objective: End-point improvement from baseline in Male Sexual Health Questionnaire Ejaculation domain (MSHQ-EjD)in men with lower urinary tract symptoms (LUTS)suggestive of benign prostatic hyperplasia (BPH) treated for 6…
- Trial name
- SAMBA-Thailand (NCT00401661)
- Testing
- Alfuzosin
- Where
- Thailand
- Volunteers
- 110 people
- Sponsor
- Sanofi
Contraception
HR-QoL and Sexuality in Mirena Inserted Contraception Users
The purpose of this study is to evaluate the changes in the quality of life, as well as in the sexual activity, in women inserted with MIRENA, a hormonal contraceptive intra-uterine system, over the first 12 months of use.
- Trial name
- NCT00498784
- Testing
- Mirena
- Where
- France
- Volunteers
- 141 people, healthy volunteers welcome
- Sponsor
- Bayer
Prostatic Diseases
Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
To assess, under daily practice conditions, the safety profile and the efficacy of a new formulation of alfuzosin administered once daily (Xatral XL) in patients with lower urinary tract symptoms (LUTS) suggestive of benign…
- Trial name
- ALEX-XL (NCT00575913)
- Testing
- Alfuzosin
- Where
- Thailand
- Volunteers
- 118 people
- Sponsor
- Sanofi
HIV Infections
A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)
The objective is to determine the effect of Isoprinosine (inosine pranobex) in homosexual male patients with AIDS related complex (ARC) in delaying the onset of AIDS.
- Trial name
- NCT00002060
- Testing
- Inosine pranobex
- Where
- United States
- Sponsor
- Newport Pharmaceuticals International
Hormone Replacement Therapy
Efficacy of Gynodian® Depot in Women With Impaired Well-being
The typical menopausal symptoms that are associated with a variety of physical and psychological changes (e.g. nervousness, anxiety, and depression) and also with impaired sexual interest and enjoyment are caused by a lack of…
- Trial name
- NCT00463450
- Testing
- Gynodian® Depot (BAY86-5032), BAY86-4980
- Volunteers
- 140 people
- Sponsor
- Bayer